Precision Oncology: Translating Discovery to the Clinic | EK45



Sessions

ORIC-944, a Potent and Selective Allosteric PRC2 Inhibitor, Mediates Antitumor Efficacy Through Distinct Mechanisms in Two Prostate Cancer Xenograft Models

Speaker(s):

Precision Pathology Through Emerging Technologies: Evaluating Tumor Burden in Melanoma Sentinel Lymph Nodes by Precise Digital Cell Counting

Speaker(s):

Personalised medicine in advanced breast cancer: AI-driven genomic test for CDK4/6 treatment response prediction

Speaker(s):

Human Papilloma Virus Integration Strictly Correlates with Global Genome Instability in Head and Neck Cancer

Speaker(s):

Cancer patient survival can be accurately parameterized, revealing time-dependent therapeutic effects and doubling the precision of small trials

Speaker(s):

Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia

Speaker(s):
  • Ekaterina Akimova, MSc, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR)

Aberrant Allelic Expressions of Imprinted Genes as Effective Biomarkers for Early Cancer Detection

Speaker(s):

Application of network-based systems pharmacology in precision medicine for T-cell acute lymphoblastic leukemia

Speaker(s):

The Chicken Chorioallantoic Membrane Tumor Assay as a Relevant In Vivo Model to Study the Impact of Hypoxia on Tumor Progression and Metastasis

Speaker(s):

Synthetic lethality-mediated precision oncology via the tumor transcriptome

Speaker(s):